Your Article Summary
See Latest ArticlesEfficacy and Safety of Denosumab in Postmenopausal Women with Osteopenia or Osteoporosis: A Systematic Review and a Meta-analysis
Hormone and Metabolic Research, 06/29/09
Anastasilakis AD et al. - Although effective as an antiresorptive agent, denosumab has not yet proved its efficacy on fracture risk reduction while increased infection risk questions its safety.
Related Articles
Osteologix to Continue Development of Osteoporosis Drug
Internet Source, 10/21/09
Relevance Score: 93%
Lifestyle increases osteoporosis risk: docs
Internet Source, 10/21/09
Relevance Score: 90%
Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
Clinical Interventions in Aging, 11/12/09
Relevance Score: 89%
A microarray based identification of osteoporosis-related genes in primary culture of human osteoblasts
Bone, 10/27/09
Relevance Score: 89%
Evaluation of Compliance with Osteoporosis Treatment Guidelines After Initiation of a Pharmacist-Run Osteoporosis Service at a Family Medicine Clinic
Annals of Pharmacotherapy, 10/15/09
Relevance Score: 89%
Today in Menopausal Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Coronary heart disease and menopause management: The swinging pendulum of HRT
Atherosclerosis, 12/04/09
The effect of short-term aerobic training on coagulation and fibrinolytic factors in sedentary healthy postmenopausal women
Maturitas, 12/04/09
Effect of minodronic acid hydrate on hip geometry in Japanese women with postmenopausal osteoporosis
Journal of Bone and Mineral Metabolism, 12/03/09